glp 1 and low carb Eating on GLP-1 Medications The Rise of GLP-1 Food

10.1016/j.freeradbiomed.2016.02.022 63 McConellG

1 Compounded GLP-1s are also associated with poorer outcomes

This review - open access on Biological Psychiatry - synthesizes emerging clinical evidence and preclinical findings, highlighting the potential of GLP-1-based therapies to enhance quit rates and reduce cardiometabolic risk in individuals who smoke, particularly those with comorbid psychiatric or metabolic conditions

The study found that dulaglutide 1.5 mg reduced the expected costs and increased the expected quality-adjusted life-years (QALYs) compared with exenatide q.w

Lets look at a real-world example

Stier, H., Vos, E., & Kenley, D